A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors

Suzanne F. Jones, Lillian L. Siu, Johanna C. Bendell, James M. Cleary, Albiruni R. Abdul Razak, Jeffrey R. Infante, Shuchi S. Pandya, Philippe L. Bédard, Kristen J. Pierce, Brett E. Houk,

Investigational New Drugs · 2015 · 170 citations · 23 references

Concepts

References

23